Skip to main content
. Author manuscript; available in PMC: 2012 Mar 22.
Published in final edited form as: Cancer Res. 2010 Mar 2;70(6):2256–2263. doi: 10.1158/0008-5472.CAN-09-4032

Figure 5. Ablation of FAK affects trastuzumab sensitivity.

Figure 5

A) BT474 cells, transfected with siRNA’s, were plated on A) laminin-5 (1 × 104 cells/well) or B) non-coated plastic, treated with trastuzumab for 2 days, and cell numbers were assessed. C) Efficiency of FAK and CD151 knockdown was determined by immunoblotting.